Chaired by Katharine Whartenby, Ph.D., members include experts in molecular medicine, aging, pathology and oncology BALTIMORE–(BUSINESS WIRE)–Akers Biosciences, Inc. (Nasdaq:… Read More…..
Excerpt only …
READ MORE BELOW
Source : Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Formation of Scientific Advisory Board
reposted by Cannabis News World